Jonathan B. Siegel - May 18, 2021 Form 4 Insider Report for Jaguar Health, Inc. (JAGX)

Role
Director
Signature
/s/ Jonathan B. Siegel
Stock symbol
JAGX
Transactions as of
May 18, 2021
Transactions value $
$0
Form type
4
Date filed
5/20/2021, 05:08 PM
Next filing
Oct 27, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JAGX Stock option (right to buy) Award $0 +72.8K $0.00 72.8K May 18, 2021 Common Stock 72.8K $1.24 Direct F1, F2, F3
transaction JAGX Restricted stock units Award $0 +36.4K $0.00 36.4K May 18, 2021 Common Stock 36.4K Direct F1, F2, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Granted pursuant to the issuer's 2014 Stock Incentive Plan.
F2 The option and restricted stock unit grants were approved by the issuer's board of directors on May 18, 2021.
F3 The options will vest in full on May 18, 2022, the first anniversary of the grant date, so long as the director continues to serve on the board of directors of the issuer.
F4 Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
F5 The restricted stock units vest in full on May 18, 2022, the first anniversary of the grant date. Vested shares will be delivered to the reporting person on the vesting date provided in the grant notice.